TWENTYEIGHT-SEVEN THERAPEUTICS
Twentyeight-Seven Therapeutics is a developer of microRNAs designed to target regulatory proteins.The company's modulating RNA which are short non-coding RNAs that inhibit target gene expression by suppressing mRNA translation and promoting mRNA decay and develop small molecules that can modulate levels of miRNAs by targeting proteins that interact with these miRNAs, enabling users to target miRNAs are directly involved in cancer initiation, progression, and metastasis.
TWENTYEIGHT-SEVEN THERAPEUTICS
Social Links:
Industry:
Biotechnology Developer Platform Health Care Life Science Therapeutics
Founded:
2016-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.twentyeight-seven.com
Total Employee:
11+
Status:
Active
Contact:
617-331-7523
Total Funding:
80 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Wordpress Plugins
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Bicara Therapeutics
Bicara Therapeutics is developing a pipeline of bifunctional antibodies that exploit the recent advances in immuno-oncology.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
HbO2 Therapeutics
HbO2 Therapeutics develops and manufactures oxygen carrying solutions.
HotSpot Therapeutics
HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.
Nuntius Therapeutics
Nuntius Therapeutics is pioneering a new class of targeted RNA, DNA and CRISPR therapies.
Tenaya Therapeutics
Tenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease.
Current Advisors List
Current Employees Featured
Founder
Investors List
Johnson & Johnson Innovation
Johnson & Johnson Innovation investment in Series A - Twentyeight-Seven Therapeutics
Astellas Venture Management
Astellas Venture Management investment in Series A - Twentyeight-Seven Therapeutics
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series A - Twentyeight-Seven Therapeutics
Vertex Ventures
Vertex Ventures investment in Series A - Twentyeight-Seven Therapeutics
MPM Capital
MPM Capital investment in Series A - Twentyeight-Seven Therapeutics
Longwood Fund
Longwood Fund investment in Series A - Twentyeight-Seven Therapeutics
Sofinnova Partners
Sofinnova Partners investment in Series A - Twentyeight-Seven Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series A - Twentyeight-Seven Therapeutics
Vertex Ventures HC
Vertex Ventures HC investment in Series A - Twentyeight-Seven Therapeutics
Astellas Venture Management
Astellas Venture Management investment in Series A - Twentyeight-Seven Therapeutics
Official Site Inspections
http://www.twentyeight-seven.com
- Host name: cloudproxy10153.sucuri.net
- IP address: 192.124.249.153
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
